Logo image of XCUR

EXICURE INC (XCUR) Stock Overview

USA - NASDAQ:XCUR - US30205M3097 - Common Stock

4.95 USD
-0.73 (-12.85%)
Last: 10/10/2025, 9:03:43 PM
4.65 USD
-0.3 (-6.06%)
After Hours: 10/10/2025, 9:03:43 PM

XCUR Key Statistics, Chart & Performance

Key Statistics
52 Week High36
52 Week Low2.15
Market Cap31.28M
Shares6.32M
Float2.33M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-3.26
PEN/A
Fwd PEN/A
Earnings (Next)11-12 2025-11-12
IPO05-09 2018-05-09
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


XCUR short term performance overview.The bars show the price performance of XCUR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20 -40

XCUR long term performance overview.The bars show the price performance of XCUR in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 40 60 80

The current stock price of XCUR is 4.95 USD. In the past month the price increased by 27.74%. In the past year, price increased by 84.7%.

EXICURE INC / XCUR Daily stock chart

XCUR Latest News, Press Relases and Analysis

XCUR Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 21.77 407.19B
AMGN AMGEN INC 13.3 156.19B
GILD GILEAD SCIENCES INC 15.14 145.40B
VRTX VERTEX PHARMACEUTICALS INC 24.07 104.55B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 60.36B
REGN REGENERON PHARMACEUTICALS 12.37 59.85B
ARGX ARGENX SE - ADR 85.97 48.77B
ONC BEONE MEDICINES LTD-ADR 5.17 35.16B
INSM INSMED INC N/A 34.31B
BNTX BIONTECH SE-ADR N/A 24.54B
NTRA NATERA INC N/A 23.23B
BIIB BIOGEN INC 9.15 21.49B

About XCUR

Company Profile

XCUR logo image Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The company is headquartered in Chicago, Illinois and currently employs 7 full-time employees. The company went IPO on 2018-05-09. The Company, through GPCR Therapeutics USA Inc. (GPCR USA), is focused on developing and commercializing an intellectual property and patents related to G-Protein Coupled Receptors. GPCR USA is conducting a Phase II clinical trial for a blood cancer treatment involving GPC-100 (Burixafor). The firm is also exploring strategic alternatives to maximize stockholder value.

Company Info

EXICURE INC

2430 N. Halsted St.

Chicago ILLINOIS 60614 US

CEO: David A. Giljohann

Employees: 7

XCUR Company Website

XCUR Investor Relations

Phone: 18476731707

EXICURE INC / XCUR FAQ

What is the stock price of EXICURE INC today?

The current stock price of XCUR is 4.95 USD. The price decreased by -12.85% in the last trading session.


What is the ticker symbol for EXICURE INC stock?

The exchange symbol of EXICURE INC is XCUR and it is listed on the Nasdaq exchange.


On which exchange is XCUR stock listed?

XCUR stock is listed on the Nasdaq exchange.


What is EXICURE INC worth?

EXICURE INC (XCUR) has a market capitalization of 31.28M USD. This makes XCUR a Nano Cap stock.


How many employees does EXICURE INC have?

EXICURE INC (XCUR) currently has 7 employees.


What are the support and resistance levels for EXICURE INC (XCUR) stock?

EXICURE INC (XCUR) has a support level at 2.35 and a resistance level at 5.69. Check the full technical report for a detailed analysis of XCUR support and resistance levels.


Should I buy EXICURE INC (XCUR) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does EXICURE INC (XCUR) stock pay dividends?

XCUR does not pay a dividend.


When does EXICURE INC (XCUR) report earnings?

EXICURE INC (XCUR) will report earnings on 2025-11-12.


What is the Price/Earnings (PE) ratio of EXICURE INC (XCUR)?

EXICURE INC (XCUR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.26).


What is the Short Interest ratio of EXICURE INC (XCUR) stock?

The outstanding short interest for EXICURE INC (XCUR) is 1.45% of its float. Check the ownership tab for more information on the XCUR short interest.


XCUR Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to XCUR. When comparing the yearly performance of all stocks, XCUR is one of the better performing stocks in the market, outperforming 85.89% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

XCUR Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to XCUR. The financial health of XCUR is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

XCUR Financial Highlights

Over the last trailing twelve months XCUR reported a non-GAAP Earnings per Share(EPS) of -3.26. The EPS decreased by -42.07% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -42.07%
ROE -88.94%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-19.64%
Sales Q2Q%N/A
EPS 1Y (TTM)-42.07%
Revenue 1Y (TTM)-100%

XCUR Forecast & Estimates


Analysts
Analysts43.33
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

XCUR Ownership

Ownership
Inst Owners12.88%
Ins Owners0.01%
Short Float %1.45%
Short Ratio0.73